Express Press Release Distribution

Accounting
Advertising
Aerospace
Agriculture
Apparel & Fashion
Automotive
Biotech
Chemicals
Computers
Construction
Consumer Services
Defense
Education
Electronics
Energy
Entertainment
Environment
Financial
Food & Beverage
Government
Healthcare
Human Resources
Industrial
International Trade
Internet & Online
Law
Management
Marketing
Media
Non Profit
Pharmaceuticals
Real Estate
Retail
Semiconductors
Small Business
Software
Sports
Telecommunications
Transportation / Logistics
Travel

EPR Archived News

Archived News 2012
~ April
~ March
~ February
~ January

Archived News 2011
~ December
~ November
~ October
~ September
~ August
~ July
~ June
~ May
~ April
~ March
~ February
~ January

Archived News 2010
Archived News 2009
Archived News 2008
Archived News 2007
Archived News 2006
Archived News 2005
Archived News 2004

 

Revolutionary Treatment Could Mean End For Varicose Vein Surgery

 

 

Released on: September 16, 2011, 2:30 pm
Author: VNUS
Industry: Healthcare

A revolutionary new treatment for varicose veins is proving a successful alternative to surgery.

The VNUS ClosureFast catheter is a minimally invasive alternative treatment, which doctors claim, results in less pain and bruising than traditional vein stripping surgery.

Using the Closure system, doctors close the diseased veins by inserting the closure catheter into a vein and heating the vein wall using temperature-controlled RF energy. As it is catheter-based, it results in little to no scarring.

Heating the vein wall causes collagen in the wall to shrink and the vein to close. After the vein is sealed shut, blood then naturally reroutes to healthy veins.

Dr Thomas Proebstle, a dermatologist and expert in venous diseases, said: “Beauty treatments and aesthetic surgery is on the increase all over the world. Quite often, this is associated with risky procedures, some pain and lengthy courses of wound healing.

“With this new, less-invasive approach, the procedure is much more gentle and smoother. The risks are much lower and the pain is kept to a low level, plus it can be administered under local anesthetic.”

Dr Proebstle, who is Professor for Dermatology at University of Pecs in Hungary, added: “Obviously this type of treatment does not need to be performed in a theatre or hospital, which improves its cost-effectiveness. It can easily be performed in an outpatient setting with the right medical facilities.”

The results of a recently published three-year-study carried out at eight european centres, which involved 225 outpatients, showed a huge success rate for the treatment.

The study showed that between 12 and 24 months after the treatment, 96.4 per cent of patients reported they had no pain. After 24 months, that number had increased to more than 99 per cent.

This bodes well for the future of vascular surgery. VNUS Closure was showcased at the NHS Expo in March as a technology that will contribute to the NHS's plan to boost productivity and efficiency by saving £1 billion.

Contact Details: COVIDIEN (UK) Commercial Ltd
154 Fareham Road
Gosport
Hampshire PO13 0AS

TEL: 0800 258 5995

 

WORD PDF PRINT

Back to previous page
Home page
Submit your press release